UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case. NASDAQ · Markets 20m ago
Alpine Completes Acquisition Of 13-property Industrial Portfolio For $117.3 Mln NASDAQ · Markets 22m ago
The Morning Risk Report: Binance Resumes Withdrawals After Suffering Biggest-Ever Crypto Hack Dow Jones · Markets 27m ago
Xcel Energy Announces $2 Bln Convertible Notes Offering, With $300 Mln Option; Shares Fall 3% NASDAQ · Markets 29m ago